Supreme Court weighs Bayer Roundup warnings case, billions in cancer claims at stake

The Supreme Court’s Roundup case turned on a question with huge consequences for consumers and injured people nationwide: can federal pesticide labeling rules shield Bayer from state lawsuits claiming the company should have warned that its weedkiller could cause cancer? The answer could determine whether thousands of Americans still have a path to sue over allegedly dangerous products, or whether a federal label approved by regulators blocks those claims.

At the center of the dispute is John Durnell, a Missouri man who said years of Roundup use caused his non-Hodgkin lymphoma. A Missouri jury awarded him $1.25 million in 2023, and Bayer is now asking the justices to erase that verdict by ruling that the Federal Insecticide, Fungicide, and Rodenticide Act preempts state failure-to-warn claims involving Roundup labels. Bayer argues it could not be forced to add a cancer warning because federal regulators did not require one.

The stakes reach far beyond one plaintiff in Missouri. The litigation has already spawned more than 100,000 lawsuits, according to SCOTUSblog, with Reuters reporting in one account that Bayer faces more than 67,000 claims. Bayer has also announced a proposed $7.25 billion settlement aimed at resolving current and future Roundup cancer claims, a sign of how much liability still hangs over the company and its Monsanto unit.

The justices heard the case on Monday, April 27, 2026, and appeared divided over whether Roundup can continue to face state-level failure-to-warn claims. A decision is expected by the end of June 2026. If Bayer wins, plaintiffs and their lawyers say the ruling could wipe out an entire line of cancer-related claims tied to Roundup and set a precedent that reaches well beyond herbicides.

The fight has also split political and public opinion. The Trump administration backed Bayer, while Senator Cory Booker filed an amicus brief supporting cancer patients and arguing the lawsuits should move forward. Ahead of argument, a Reuters-Ipsos poll found that most Americans worry about pesticides and oppose shielding companies from lawsuits over hazardous products, a sign that public sentiment may be wary of weakening consumer protections. For Bayer, a ruling in its favor would provide a powerful legal shield. For people alleging injury from Roundup, it could close one of the last remaining doors to accountability.